OpenEvidence Rips Doximity Harassment, Defamation Counterclaims

Medical-technology company OpenEvidence Inc. accused rival Doximity Inc. of using “fatally deficient” false advertising and defamation counterclaims to distract from the AI trade secrets theft it’s accused of.

Statements that Doximity deems false or defamatory are either demonstrably true, attributable to third parties, or opinion, OpenEvidence said Friday in a motion to dismiss in the US District Court for the District of Massachusetts. OpenEvidence called Doximity’s “retaliatory counterclaims” an effort to “recast itself as the victim” and a “transparent attempt to distract from its own admitted misconduct.”

The Nov. 7 motion attempts to refocus the dispute on Doximity’s alleged “prompt ...